Bordetellaand Related Genera

Carl-Heinz Wirsing Von KÖnig; Marion Riffelmann; Tom Coenye

doi:10.1128/9781555817381.ch45

Chapter 45 : Bordetella and Related Genera

Authors: Carl-Heinz Wirsing Von KÖnig, Marion Riffelmann, Tom Coenye

Content Type: Reference

Publication Year: 2015

Category: Clinical Microbiology

Book DOI: 10.1128/9781555817381

Chapter DOI: 10.1128/9781555817381.ch45

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Preview this chapter:

Bordetella and Related Genera, Page 1 of 2

< Previous page | Next page > /docserver/preview/fulltext/10.1128/9781555817381/9781555817381.ch45-1.gif /docserver/preview/fulltext/10.1128/9781555817381/9781555817381.ch45-2.gif

There is no abstract provided for this chapter. We are in the process of generating a full text preview. Please bookmark and return later.

Citation: Von KÖnig C, Riffelmann M, Coenye T. 2015. Bordetella and Related Genera, p 838-850. In Jorgensen J, Pfaller M, Carroll K, Funke G, Landry M, Richter S, Warnock D (ed), Manual of Clinical Microbiology, Eleventh Edition. ASM Press, Washington, DC. doi: 10.1128/9781555817381.ch45

Highlighted Text: Show | Hide

Full text loading...

Figures

Bordetellaand Related Genera

[com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/author/10.1128/9781555817381.mcm11.ch45-1,webId=/content/author/10.1128/9781555817381.mcm11.ch45-1,properties={foaf_givenname=Carl-Heinz Wirsing, foaf_name=Carl-Heinz Wirsing Von KÖnig, foaf_surname=Von KÖnig}], com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/author/10.1128/9781555817381.mcm11.ch45-2,webId=/content/author/10.1128/9781555817381.mcm11.ch45-2,properties={foaf_givenname=Marion, foaf_name=Marion Riffelmann, foaf_surname=Riffelmann}], com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/author/10.1128/9781555817381.mcm11.ch45-3,webId=/content/author/10.1128/9781555817381.mcm11.ch45-3,properties={foaf_givenname=Tom, foaf_name=Tom Coenye, foaf_surname=Coenye}]]

/content/10.1128/9781555817381.mcm11.ch45.ch45.fig001

FIGURE 1

Schematic graph of symptoms and diagnostic procedures in pertussis. d, days. (Courtesy of Nicole Guiso, Institut Pasteur, Paris, France.) doi:10.1128/9781555817381.ch45.f1

10.1128/9781555817381/9781555817381.ch45.f1_thmb.gif

10.1128/9781555817381/9781555817381.ch45.f1.gif

FIGURE 1

Schematic graph of symptoms and diagnostic procedures in pertussis. d, days. (Courtesy of Nicole Guiso, Institut Pasteur, Paris, France.) doi:10.1128/9781555817381.ch45.f1

References

/content/book/10.1128/9781555817381.mcm11.ch45

1. Busse HJ,,, Stolz A,. 2006. Achromobacter, Alcaligenes and related genera, p 675–700. In Dworkin M,, Falkow S,, Rosenberg E,, Schleifer KH,, Stackebrandt E ( ed), The Prokaryotes, vol 5. Springer, Heidelberg, Germany.

2. Kersters K,, Hinz KH,, Hertle A,, Segers P,, Lievens A,, Siegmann O,, DeLey J. 1984. Bordetella avium sp. nov., isolated from the respiratory tracts of turkeys and other birds. Int J Syst Bacteriol 34: 56– 70.

3. Mattoo S,, Cherry JD. 2005. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev 18: 326– 382.

4. Vandamme P,, Hommez J,, Vancanneyt M,, Monsieurs M,, Hoste B,, Cookson B,, Wirsing von Konig CH,, Kersters K,, Blackall PJ. 1995. Bordetella hinzii sp. nov., isolated from poultry and humans. Int J Syst Bacteriol 45: 37– 45.

5. Vandamme P,, Heyndrickx M,, Vancanneyt M,, Hoste B,, De Vos P,, Falsen E,, Kersters K,, Hinz KH. 1996. Bordetella trematum sp. nov., isolated from wounds and ear infections in humans, and reassessment of Alcaligenes denitrificans Rüger and Tan 1983. Int J Syst Bacteriol 46: 849– 858.

6. Von Witzingerode F,, Schattke A,, Siddiqui RA,, Rösick U,, Göbel UB,, Gross R. 2001. Bordetella petrii sp. nov., isolated from an anaerobic bioreactor, and emended description of the genus Bordetella. Int J Syst Evol Microbiol 51: 1257– 1265.

7. Weyant RS,, Hollis DG,, Weaver RE,, Amin MF,, Steigerwalt AG,, O’Connor SP,, Whitney AM,, Daneshvar ML,, Moss CW,, Brenner DJ. 1995. Bordetella holmesii sp. nov., a new gram-negative species associated with septicemia. J Clin Microbiol 33: 1– 7.

8. Harrington AT,, Castellanos JA,, Ziedalski TM,, Clarridge JE III,, Cookson BT. 2009. Isolation of Bordetella avium and novel Bordetella strain from patients with respiratory disease. Emerg Infect Dis 15: 72– 74.

9. Ko KS,, Pecj KR,, Oh WS,, Lee NY,, Lee JH,, Song JH. 2005. New species of Bordetella, Bordetella ansorpii sp. nov., isolated from the purulent exudate of an epidermal cyst. J Clin Microbiol 43: 2516– 2519.

10. Parkhill J,, Sebaihia M,, Preston A,, Murphy LD,, Thomson N,, Harris DE,, Holden MT,, Churcher CM,, Bentley SD,, Mungall KL,, Cerdeño-Tárraga AM,, Temple L,, James K,, Harris B,, Quail MA,, Achtman M,, Atkin R,, Baker S,, Basham D,, Bason N,, Cherevach I,, Chillingworth T,, Collins M,, Cronin A,, Davis P,, Doggett J,, Feltwell T,, Goble A,, Hamlin M,, Hauser H,, Holroyd S,, Jagels K,, Leather S,, Moule S,, Norberczak H,, O ’Neil S,, Ormond D,, Price C,, Rabbinowitsch E,, Rutter S,, Sanders M,, Saunders D,, Seeger K,, Sharp S,, Simmonds M,, Skelton J,, Squares R,, Squares S,, Stevens K,, Unwin L,, Whitehead S,, Barrell BG,, Maskell DJ. 2003. Comparative analysis of the genome sequences of Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica. Nat Genet 35: 32– 40.

11. Coenye T,, Vancanneyt M,, Cnockaert M,, Falsen E,, Swings J,, Vandamme P. 2003. Kerstersia gyiorum gen. nov., sp. nov., a novel Alcaligenes faecalis-like organism isolated from human clinical samples, and reclassification of Alcaligenes denitrificans Rüger and Tan 1983 as Achromobacter denitrificans comb. nov. Int J Syst Evol Microbiol. 53: 1825– 1831.

12. Van Trappen S,, Tan TL,, Samyn E,, Vandamme P. 2005. Alcaligenes aquatilis sp. nov., a novel bacterium from sediments of the Weser Estuary, Germany, and a salt marsh on Shem Creek in Charleston Harbor, USA. Int J Syst Evol Microbiol 55: 2571– 2575.

13. Coenye T,, Vancanneyt M,, Falsen E,, Swings J,, Vandamme P. 2003. Achromobacter insolitus sp. nov. and Achromobacter spanius sp. nov., from human clinical samples. Int J Syst Evol Microbiol 53: 1819– 1824.

14. Gomila M,, Tvrzová L,, Teshim A,, Sedlácek I,, González-Escalona N,, Zdráhal Z,, Sedo O,, González JF,, Bennasar A,, Moore ER,, Lalucat J,, Murialdo SE. 2011. Achromobacter marplatensis sp. nov., isolated from a pentachlorophenol-contaminated soil. Int J Syst Evol Microbiol 61: 2231– 2237.

15. Vandamme P,, Moore RE,, Cnockaert M,, De Brandt E,, Svensson-Stadler L,, Houf K,, Spilker T,, LiPuma JJ. 2013. Achromobacter animicus sp. nov., Achromobacter mucicolens sp. nov., Achromobacter pulmonis sp. nov. and Achromobacter spiritinus sp. nov., from human clinical samples. Syst Appl Microbiol 36: 1– 10.

16. Vandamme P,, Moore ERB,, Cnockaert M,, Peeters C,, Svensson-Stadler L,, Houf K,, Spilker T,, LiPuma JJ. 2013. Classification of Achromobacter genogroups 2, 5, 7 and 14 as Achromobacter insuavis sp. nov., Achromobacter aegrifaciens sp. nov., Achromobacter anxifer sp. nov. and Achromobacter dolens sp. nov., respectively. Syst Appl Microbiol 36: 474– 482.

17. Yabuuchi E,, Kawamura Y,, Kosako Y,, Ezaki T. 1998. Emendation of the genus Achromobacter and Achromobacter xylosoxidans (Yabuuchi and Yano) and proposal of Achromobacter ruhlandii (Packer and Vishniac) comb. nov., Achromobacter piechaudii (Kiredjian et al.) comb. nov., and Achromobacter xylosoxidans subsp. denitrificans (Rüger and Tan) comb. nov. Microbiol Immunol 42: 429– 438.

18. Spilker T,, Vandamme P,, LiPuma JJ. 2012. A multilocus sequence typing scheme implies population structure and reveals several putative novel Achromobacter species. J Clin Microbiol 50: 3010– 3015.

19. Coenye T,, Vanlaere E,, Samyn E,, Falsen E,, Vandamme P. 2005. Advenella incenata gen. nov., sp. nov., a novel member of the Alcaligenaceae, isolated from various clinical samples. Int J Syst Evol Microbiol 55: 251– 256.

20. Gibello A,, Vela AL,, Martin M,, Barra-Caracciolo A,, Grenni P,, Fernandez-Garayzabal JF. 2009. Reclassification of the members of the genus Tetrathiobacter Ghosh et al. 2005 to the genus Advenella Coenye et al. 2005. Int J Syst Evol Microbiol 59: 1914– 1918.

21. Kämpfer P,, Falsen E,, Langer S,, Lodders N,, Busse HJ. 2010. Paenalcaligenes hominis gen. nov., sp. nov., a new member of the family Alcaligenaceae. Int J Syst Evol Microbiol 60: 1537– 1542.

22. Bordet J,, Gengou U. 1906. Le microbe de la coqueluche. Ann Inst Pasteur 20: 48– 68.

23. Sebaihia M,, Preston A,, Maskell DJ,, Kuzmiak H,, Connell TD,, King ND,, Orndorff PE,, Miyamoto DM,, Thomson NR,, Harris D,, Goble A,, Lord A,, Murphy L,, Quail MA,, Rutter S,, Squares R,, Squares S,, Woodward J,, Parkhill J,, Temple LM. 2006. Comparison of the genome sequence of the poultry pathogen Bordetella avium with those of B. bronchiseptica, B. pertussis and B. parapertussis reveals extensive diversity in surface structures associated with host interaction. J Bacteriol 188: 6002– 6015.

24. Gross R,, Guzman CA,, Sebaihia M,, Martins dos Santos VAP,, Pieper DH,, Koebnik R,, Lechner M,, Bartels D,, Buhrmeister J,, Choudhouri JV,, Ebensen T,, Gaigalat L,, Hermann S,, Khachane AN,, Larisch C,, Link S,, Linke B,, Meyer F,, Mormann S,, Nakunst D,, Rückert C,, Schneiker-Bekel S,, Schulze K,, Vorhölter FJ,, Yevsa T,, Engle JT,, Goldman WE,, Pühler A,, Göbel UB,, Goesmann A,, Blöcker H,, Kaiser O,, Martinez-Arias R. 2008. The missing link: Bordetella petrii is endowed with both the metabolic versatility of environmental bacteria and virulence traits of pathogenic bordetellae. BMC Genomics 9: 449.

25. Park J,, Zhang Y,, Buboltz AM,, Zhang X,, Schuster SC,, Ahuja U,, Liu M,, Miller JF,, Sebaihia M,, Bentley SD,, Parkhill J,, Harvill ET. 2012. Comparative genomics of the classical Bordetella subspecies: the evolution and exchange of virulence associated diversity amongst closely related pathogens. BMC Genomics 13: 545.

26. Gerlach G,, Janzen S,, Beier D,, Gross R. 2004. Functional characterization of the BvgAS two-component system of Bordetella holmesii. Microbiology 150: 3715– 3729.

27. Hewlett EL,, Donato DM,, Gray MC. 2006. Macrophage cytotoxicity produced by adenylate cyclase toxin from Bordetella pertussis: more than just making AMP. Mol Microbiol 59: 447– 459.

28. Hijnen M,, He Q,, Schepp R,, van Gageldonk P,, Mertsola J,, Mooi FR,, Berbers GA. 2008. Antibody responses to defined regions of the Bordetella pertussis virulence factor pertactin. Scand J Infect Dis 40: 92– 104.

29. Bodilis H,, Guiso N. 2013. Virulence of pertactin-negative Bordetella pertussis isolates from infants, France. Emerg Infect Dis 3: 471– 474.

30. Hegerle N,, Paris AS,, Brun D,, Dore G,, Njamkepo E,, Guillot S,, Guiso N. 2012. Evolution of French Bordetella pertussis and Bordetella parapertussis isolates: increase of Bordetellae not expressing pertactin. Clin Microbiol Infect 18: E340– E346.

31. Queenan AM,, Cassidy PK,, Evangelista A. 2013. Pertactin-negative variants of Bordetella pertussis in the United States. N Engl J Med 368: 583– 584.

32. Vandamme P,, De Brandt E,, Houf K,, De Baere T. 2012. Kerstersia similis sp. nov., isolated from human clinical samples. Int J Syst Evol Microbiol 62: 2156– 2159.

33. Wright RM,, Moore JE,, Shaw A,, Dunbar K,, Dodd M,, Webb K,, Redmond AO,, Crowe M,, Murphy PG,, Peacock S,, Elborn JS. 2001. Improved cultural detection of Burkholderia cepacia from sputum in patients with cystic fibrosis. J Clin Pathol 54: 803– 805.

34. Rehfuss M,, Urban J. 2005. Alcaligenes faecalis subsp. phenolicus subsp. nov. a phenol-degrading, denitrifying bacterium isolated from a graywater bioprocessor. Syst Appl Microbiol 28: 421– 429.

35. Schroll G,, Busse HJ,, Parrer G,, Rölleke S,, Lubitz W,, Denner EB. 2001. Alcaligenes faecalis subsp. parafaecalis subsp. nov., a bacterium accumulating poly-beta-hydroxybutyrate from acetone-butanol bioprocess residues. Syst Appl Microbiol 24: 37– 43.

36. Kersters K,,, De Ley J,. 1984. Genus Alcaligenes Castellani and Chalmers 1919, 936 AL, p 361– 373. In Krieg NR,, Holt JG ( ed), Bergey’s Manual of Systematic Bacteriology, vol 1. Williams & Wilkins Co, Baltimore, MD.

37. Brinig MM,, Cummings CA,, Sanden GN,, Stefanelli P,, Lawrence A,, Relman DA. 2006. Significant gene order and expression differences in Bordetella pertussis despite limited gene content variation. J Bacteriol 188: 2375– 2382.

38. Guiso N. 2009. Bordetella pertussis and pertussis vaccines. Clin Infect Dis 49: 1565– 1569.

39. Watanabe M,, Connelly B,, Weiss AA. 2006. Characterization of serological responses to pertussis. Clin Vaccine Immunol 13: 341– 348.

40. Wirsing von König CH,, Halperin S,, Riffelmann M,, Guiso N. 2002. Pertussis of adults and infants. Lancet Infect Dis 2: 744– 750.

41. Plotkin S. 2005. The global pertussis initiative: process overview. Pediatr Infect Dis J 24: S5– S98.

42. Cagney M,, McIntyre PB,, Heron L,, Giammanco A,, MacIntyre CR. 2008. The relationship between pertussis symptomatology, incidence and serology in adolescents. Vaccine 26: 5547– 5553.

43. Ward JI,, Cherry JD,, Chang SJ,, Partridge S,, Keitel W,, Edwards K,, Lee M,, Treanor J,, Greenberg DP,, Barenkamp S,, Bernstein DI,, Edelman R,, APERT Study Group. 2006. Bordetella pertussis infections in vaccinated and unvaccinated adolescents and adults as assessed in a national prospective randomized acellular pertussis vaccine trial (APERT). Clin Infect Dis 43: 151– 157.

44. Kretzschmar M,, Teunis PF,, Pebody RG. 2010. Incidence and reproduction numbers of pertussis: estimates from serological and social contact data in five European countries. PLoS Med 7: e1000291.

45. Wendelboe AM,, Hudgens MG,, Poole C,, van Rie A. 2007. Estimating the role of casual contacts from the community in transmission of Bordetella pertussis to young infants. Emerg Themes Epidemiol 4: 15.

46. Jackson DW,, Rohani P. 2014. Perplexities of pertussis: recent global epidemiological trends and their potential causes. Epidemiol Infect 142: 672– 684.

47. Njamkepo E,, Bonacorsi S,, Debruyne M,, Gibaud SA,, Guillot S,, Guiso N. 2011. Significant finding of Bordetella holmesii in nasopharyngeal samples from French patients with suspected pertussis. J Clin Microbiol 49: 4347– 4348.

48. Rodgers L,, Martin SW,, Cohn A,, Budd J,, Marcon M,, Teranella A,, Mandal S,, Salamon D,, Leber A,, Tondella ML,, Tatti K,, Spicer K,, Emanuel A,, Koch E,, McGlone L,, Pawlowski L,, Lemaille-Williams W,, Tucker N,, Iyer R,, Clark TA,, Dorio M. 2013. Epidemiological and laboratory features of a large outbreak of pertussis-like illnesses associated with co-circulating Bordetella holmesii and Bordetella pertussis, Ohio, 2010-2011. Clin Infect Dis 56: 322– 331.

49. Kanellopoulou M,, Pournaras S,, Iglezos H,, Skarmoutsou N,, Papafrangas E,, Maniatis AN. 2004. Persistent colonization of nine cystic fibrosis patients with an Achromobacter ( Alcaligenes) xylosoxidans clone. Eur J Clin Microbiol Infect Dis 23: 336– 339.

50. Krzewinski JW,, Nguyen CD,, Foster JM,, Burns JL. 2001. Use of random amplified polymorphic DNA PCR to examine epidemiology of Stenotrophomonas maltophilia and Achromobacter ( Alcaligenes) xylosoxidans from patients with cystic fibrosis. J Clin Microbiol 39: 3597– 3602.

51. Raso T,, Bianco O,, Grosso B,, Zucca M,, Savoia D. 2008. Achromobacter xylosoxidans respiratory tract infections in cystic fibrosis patients. APMIS 116: 837– 841.

52. Van Daele S,, Verhelst R,, Claeys G,, Verschraegen G,, Franckx H,, Van Simaey L,, de Ganck C,, De Baets F,, Vaneechoutte M. 2005. Shared genotypes of Achromobacter xylosoxidans strains isolated from patients at a cystic fibrosis rehabilitation center. J Clin Microbiol 43: 2998– 3002.

53. Ridderberg W,, Bendstrup KE,, Olesen HV,, Jensen-Fangel S,, Nørskov-Lauritsen N. 2011. Marked increase in incidence of Achromobacter xylosoxidans infections caused by sporadic acquisition from the environment. J Cyst Fibros 10: 466– 469.

54. Hansen CR,, Pressler T,, Ridderberg W,, Johansen HK,, Skov M. 2013. Achromobacter species in cystic fibrosis: cross-infection caused by indirect patient-to-patient contact. J Cyst Fibros 12: 609– 615.

55. Patriarca PA,, Biellik RJ,, Sanden G,, Burstyn DG,, Mitchell PD,, Silverman PR,, Davis JP,, Manclark CR. 1998. Sensitivity and specificity of clinical case definitions of pertussis. Am J Public Health 78: 833– 836.

56. Haberling DL,, Holman,, Paddock CD,, Murphy TV. 2009. Infant and maternal risk factors for pertussis-related infant mortality in the United States, 1999 to 2004. Pediatr Infect Dis J 28: 194– 198.

57. Paddock CD,, Sanden GN,, Cherry JD,, Gal AA,, Langston C,, Tatti KM,, Wu KH,, Goldsmith CS,, Greer PW,, Montague JL,, Eliason MT,, Holman RC,, Guarner J,, Shieh WJ,, Zaki SR. 2008. Pathology and pathogenesis of fatal Bordetella pertussis infections in infants. Clin Infect Dis 47: 328– 338.

58. Cosnes-Lambe C,, Raymond J,, Chalumeau M,, PonsCatalano C,, Moulin F,, de Suremain N,, Reglier-Pupet H,, Lebon P,, Poyart C,, Grimprel E. 2008. Pertussis and respiratory syncytial virus infections. Eur J Pediatr 167: 1017– 1019.

59. Moissenet D,, Bingen E,, Arlet G,, Vu-Thien H. 2005. Use of 16S rRNA gene sequencing for identification of Pseudomonas-like isolates from sputum of patients with cystic fibrosis. Pathol Biol (Paris) 53: 500– 502.

60. Rath BA,, Register KB,, Wall J,, Sokol DM,, van Dyke RB. 2008. Persistent Bordetella bronchiseptica pneumonia in an immunocompetent infant and genetic comparison of clinical isolates with kennel cough vaccine strains. Clin Infect Dis 46: 905– 908.

61. Arvand M,, Feldhues R,, Mieth M,, Kraus T,, Vandamme P. 2004. Chronic cholangitis caused by Bordetella hinzii in a liver transplant recipient. J Clin Microbiol 42: 2335– 2337.

62. Fry NK,, Duncan J,, Edwards MT,, Tilley RE,, Chitvanis D,, Harman R,, Hammerton H,, Dalton L. 2007. A UK clinical isolate of Bordetella hinzii from a patient with myelodysplastic syndrome. J Med Microbiol 56: 1700– 1703.

63. Hristov AC,, Auwaerter PG,, Romagnoli M,, Carroll KC. 2008. Bordetella hinzii septicaemia in association with Epstein-Barr virus viremia and an Epstein-Barr virus-associated diffuse large B-cell lymphoma. Diagn Microbiol Infect Dis 61: 484– 486.

64. Kattar MM,, Chavez JF,, Limaye AP,, Rassoulian-Barrett SL,, Yarfitz SL,, Carlson LC,, Houze Y,, Swanzy S,, Wood BL,, Cookson BT. 2000. Application of 16S rRNA sequencing to identify Bordetella hinzii as the causative agent of fatal septicemia. J Clin Microbiol 38: 789– 794.

65. Daxboeck F,, Goerzer E,, Apfalter P,, Nehr M,, Krause R. 2004. Isolation of Bordetella trematum from a diabetic leg ulcer. Diabet Med 21: 1247– 1248.

66. Fry NK,, Duncan J,, Malnick H,, Cockcroft PM. 2007. The first UK isolate of “ Bordetella ansorpii” from an immunocompromised patient. J Med Microbiol 56: 993– 995.

67. Fry NK,, Duncan J,, Malnick H,, Warner M,, Smith AJ,, Jackson MS,, Ayoub A. 2005. Bordetella petrii clinical isolate. Emerg Infect Dis 11: 1131– 1133.

68. Stark D,, Riley LA,, Harkness J,, Mariott D. 2007. Bordetella petrii from a clinical sample in Australia: isolation and molecular identification. J Med Microbiol 56: 435– 437.

69. Wang F,, Grundmann S,, Schmid M,, Dörfler U,, Roherer S,, Charles Munch J,, Hartmann A,, Jiang X,, Schroll R. 2007. Isolation and characterization of 1,2,4-trichlorbenzene mineralizing Bordetella sp. and its bioremediation potential in soil. Chemosphere 76: 896– 902.

70. Coenye T,, Goris J,, Spiker T,, Vandamme P,, LiPuma JJ. 2002. Characterization of unusual bacteria isolated from respiratory secretions of cystic fibrosis patients, and description of Inquilinus limosus gen. nov. sp. nov. J Clin Microbiol 40: 2062– 2069.

71. Spangler SK,, Visalli MA,, Jacobs MR,, Appelbaum PC. 1996. Susceptibilities of non- Pseudomonas aeruginosa gram-negative nonfermentative rods to ciprofloxacin, ofloxacin, levofloxacin, D-ofloxacin, sparfloxacin, ceftazidime, piperacillin, piperacillin-tazobactam, trimethoprim-sulfamethoxazole, and imipenem. Antimicrob Agents Chemother 40: 772– 775.

72. Spicuzza L,, Sciuto C,, Vitaliti G,, Di Dio G,, Leonardi S,, La Rosa M. 2009. Emerging pathogens in cystic fibrosis: ten years of follow-up in a cohort of patients. Eur J Clin Microbiol Infect Dis 28: 191– 195.

73. Aisenberg G,, Rolston KV,, Safdar A. 2004. Bacteremia caused by Achromobacter and Alcaligenes species in 46 patients with cancer (1989–2003). Cancer 101: 2134– 2140.

74. Gómez-Cerezo J,, Suárez I,, Ríos JJ,, Peña P,, García de Miguel MJ,, de José M,, Monteagudo O,, Linares P,, Barbado-Cano A,, Vázquez JJ. 2003. Achromobacter xylosoxidans bacteremia: a 10-year analysis of 54 cases. Eur J Clin Microbiol Infect Dis 22: 360– 363.

75. Molina-Cabrillana J,, Santana-Reyes C,, González-García A,, Bordes-Benítez A,, Horcajada I. 2007. Outbreak of Achromobacter xylosoxidans pseudobacteremia in a neonatal care unit related to contaminated chlorhexidine solution. Eur J Clin Microbiol Infect Dis 26: 435– 437.

76. Kiredjian M,, Holmes B,, Kersters K,, Guilvout I,, De Ley J. 1986. Alcaligenes piechaudii sp. nov., a new species from human clinical specimens and the environment. Int J Syst Bacteriol 36: 282– 287.

77. Krause ML,, Sohail MR,, Patel R,, Wittich CM. 2012. Achromobacter piechaudii bloodstream infection in an immunocompetent host. Am J Case Rep 13: 265– 267.

78. Burns JL,, Emerson J,, Stapp JR,, Yim DL,, Krzewinski J,, Louden L,, Ramsey BW,, Clausen CR. 1998. Microbiology of sputum from patients at cystic fibrosis centers in the United States. Clin Infect Dis 27: 158– 163.

79. De Baets F,, Schelstraete P,, Van Daele S,, Haerynck F,, Vaneechoutte M. 2007. Achromobacter xylosoxidans in cystic fibrosis: prevalence and clinical relevance. J Cyst Fibros 6: 75– 78.

80. Degand N,, Carbonelle E,, Dauphin B,, Beretti JL,, Le Bourgeois M,, Sermet-Gaudelus I,, Segonds C,, Berche P,, Nassif X,, Ferroni A. 2008. Matrix-assisted laser desorption ionization–time of flight mass spectrometry of nonfermenting Gram-negative bacilli isolated from cystic fibrosis patients. J Clin Microbiol 46: 3361– 3367.

81. Barrado L,, Brañas P,, Orellana MA,, Martínez MT,, García G,, Otero JR,, Chaves F. 2013. Molecular characterization of Achromobacter isolates from cystic fibrosis and non-cystic fibrosis patients in Madrid, Spain. J Clin Microbiol 51: 1927– 1930.

82. Spilker T,, Liwienski AA,, LiPuma JJ. 2008. Identification of Bordetella spp. in respiratory specimens from individuals with cystic fibrosis. Clin Microbiol Infect 14: 504– 506.

83. Hansen CR,, Pressler T,, Nielsen KG,, Jensen PO,, Bjarnsholt T,, Helby N. 2010. Inflammation in Achromobacter xylosoxidans infected cystic fibrosis patients. J Cyst Fibros 9: 51– 58.

84. Rønne Hansen C,, Pressler T,, Høiby N,, Gormsen M. 2006. Chronic infection with Achromobacter xylosoxidans in cystic fibrosis patients; a retrospective case control study. J Cyst Fibros 5: 245– 251.

85. Bizet J,, Bizet C. 1997. Strains of Alcaligenes faecalis from clinical material. J Infect 35: 167– 169.

86. Fenollar F,, Roux V,, Stein A,, Drancourt M,, Raoult D. 2006. Analysis of 525 samples to determine the usefulness of PCR amplification and sequencing of the 16S rRNA gene for diagnosis of bone and joint infections. J Clin Microbiol 44: 1018– 1028.

87. Wellinghausen N,, Wirths B,, Poppert S. 2006. Fluorescence in situ hybridization for rapid identification of Achromobacter xylosoxidans and Alcaligenes faecalis recovered from cystic fibrosis patients. J Clin Microbiol 44: 3415– 3417.

88. Almuzara MN,, Barberis CM,, Traglia GM,, Ordoñez AM,, Famiglietti AM,, Ramirez MS,, Vay CA. 2012. Isolation of Kerstersia gyiorum from a patient with cholesteatomatous chronic otitis media. J Clin Microbiol 50: 3809– 3811.

89. Pence MA,, Sharon J,, McElvania Tekippe E,, Pakalniskis BL,, Ford BA,, Burnham CA. 2013. Two cases of Kerstersia gyiorum isolated from sites of chronic infection. J Clin Microbiol 51: 2001– 2004.

90. Riffelmann M,, Wirsing von König CH,, Caro V,, Guiso N. 2005. Nucleic acid amplification tests for diagnosis of Bordetella infections. J Clin Microbiol 43: 4925– 4929.

91. Fry NK,, Duncan J,, Wagner K,, Tzivra O,, Doshi N,, Litt DJ,, Crowcroft N,, Miller E,, George RC,, Harrison TG. 2009. Role of PCR in the diagnosis of pertussis infection in infants: 5 years’ experience of provision of a same-day real-time PCR service in England and Wales from 2002 to 2007. J Med Microbiol 58: 1023– 1029.

92. Loeffelsholz M. 2012. Towards improved accuracy of Bordetella pertussis nucleic acid amplification tests. J Clin Microbiol 50: 2186– 2190.

93. Muyldermans G,, Soetens O,, Antoine M,, Bruisten S,, Vincart B,, Doucet K,, Populaire F,, Fry NK,, Olcen P,, Scheftel JM,, Senterre JM,, van der Zee A,, Riffelmann M,, Pierard D,, Lauwers S. 2005. External quality assessment for molecular detection of Bordetella pertussis in European laboratories. J Clin Microbiol 43: 30– 35.

94. Templeton KE,, Scheltinga SA,, van der Zee A,, Diederen BMW,, Kruijssen AM,, Goossens H,, Kuijper E,, Claas ECJ. 2003. Evaluation of real-time PCR for detection of and discrimination between Bordetella pertussis, Bordetella parapertussis, and Bordetella holmesii for clinical diagnosis. J Clin Microbiol 41: 4121– 4126.

95. Waters V,, Jamieson F,, Richardson SE,, Finkelstein M,, Wormsbecker A,, Halperin SA. 2009. Outbreak of atypical pertussis detected by polymerase chain reaction in immunized preschool-aged children. Pediatr Infect Dis J 28: 582– 587.

96. Tizalova A,, Guiso N,, Guillot S. 2013. Insertion sequences shared by Bordetella species and implications for the biological diagnosis of pertussis syndrome. Eur J Clin Microbiol Infect Dis 32: 89– 96.

97. Roorda l,, Buitenwerf J,, Ossenwaarde JM,, van der Zee A. 2011. A real-time PCR assay with improved specificity for detection and discrimination of all clinically relevant Bordetella species by the presence and distribution of three insertion sequence elements. BMC Res Notes 4: 11.

98. Tatti KM,, Sparks KN,, Boney KO,, Tondella MT. 2011. Novel multitarget real-time PCR assay for rapid detection of Bordetella species in clinical specimens. J Clin Microbiol 49: 4059– 4066.

99. Register KB,, Nicholson TL. 2007. Misidentification of Bordetella bronchiseptica as Bordetella pertussis using a newly described real-time PCR targeting the pertactin gene. J Med Microbiol 56: 1608– 1610.

100. Reischl U,, Lehn N,, Sanden GN,, Loeffelholz MJ. 2001. Real-time PCR assay targeting IS481 of Bordetella pertussis and molecular basis for detecting Bordetella holmesii. J Clin Microbiol 39: 1963– 1966.

101. Mandal S,, Tatti KM,, Woods-Stout D,, Cassiday PK,, Faulkner AE,, Griffith MM,, Jackson ML,, Pawlowski LC,, Wagner B,, Barnes M,, Cohn AC,, Gershman KA,, Messonier NE,, Clark TA,, Tondella ML,, Martin SW. 2012. Pertussis pseudo-outbreak linked to specimens contaminate by Bordetella pertussis DNA from clinical surfaces. Pediatrics 129: e24– e30.

102. Wirsing von König CH,,, Riffelmann M,,, Coeyne T,. 2011. Bordetella and related genera, p 739–750. In Versalovic J,, Carroll KC,, Jorgensen JG,, Funke G,, Landry ML,, Warnock DW ( ed), Manual of Clinical Microbiology, 10th ed. ASM Press, Washington, DC.

103. Henry DA,, Campbell ME,, LiPuma JJ,, Speert DP. 1997. Identification of Burkholderia cepacia isolates from patients with cystic fibrosis and use of a simple new selective medium. J Clin Microbiol 35: 614– 619.

104. Moore JE,, Xu J,, Millar BC,, Courtney J,, Elborn JS. 2003. Development of a Gram-negative selective agar (GNSA) for the detection of Gram-negative microflora in sputa in patients with cystic fibrosis. J Appl Microbiol 95: 160– 166.

105. Snyder JW,, Munier GK,, Johnson CL. 2008. Direct comparison of the BD Phoenix system with the MicroScan WalkAway system for identification and antimicrobial susceptibility testing of Enterobacteriaceae and nonfermentative Gram-negative organisms. J Clin Microbiol 46: 2327– 2333.

106. Register KB,, Sacco RE,, Nordholm GE. 2003. Comparison of ribotyping and restriction enzyme analysis for inter- and intraspecies discrimination of Bordetella avium and Bordetella hinzii. J Clin Microbiol 41: 1512– 1519.

107. Bosshard PP,, Zbinden R,, Abels S,, Böddinghaus B,, Altwegg A,, Böttger EC. 2006. 16S rRNA gene sequencing versus the API 20 NE system and the VITEK 2 ID-GNB card for identification of nonfermenting Gram-negative bacteria in the clinical laboratory. J Clin Microbiol 44: 1359– 1366.

108. Fontana C,, Favaro M,, Pellicioni M,, Pistoia ES,, Favalli C. 2005. Use of the MicroSeq 500 16S rRNA gene-based sequencing for identification of bacterial isolates that commercial automated systems failed to identify. J Clin Microbiol 43: 615– 619.

109. Panagopulos MI,, Saint Jean M,, Brun D,, Guiso N,, Bekal N,, Ovetchkine P,, Tapiero B. 2010. Bordetella holmesii bacteremia in asplenic children: report of four cases initially misidentified as Acinetobacter lwoffii. J Clin Microbiol 48: 3462– 3464.

110. Liu L,, Coenye T,, Burns JL,, Whitby PW,, Stull TL,, LiPuma JJ. 2002. Ribosomal DNA-directed PCR for identification of Alcaligenes ( Achromobacter) xylosoxidans recovered from sputum samples from cystic fibrosis patients. J Clin Microbiol 40: 1210– 1213.

111. Jacquier H,, Carbonelle E,, Corvec S,, Illiaquer M,, Le Monnier A,, Bille E,, Zahar JR,, Beretti JL,, Jauréguy F,, Fihman V,, Tankovic J,, Cattoir V. 2011. Revisited distribution of nonfermenting Gram-negative bacili clinical isolates. Eur J Clin Microbiol Infect Dis 30: 1579– 1586.

112. Fernandez-Olmos A,, Garcia-Castillo M,, Morosini MI,, Lamas A,, Maiz L,, Canton R. 2012. MALDI-TOF MS improves routine identification of non-fermenting Gram negative isolates from cystic fibrosis patients. J Cyst Fibros 11: 59– 62.

113. Marko DC,, Saffert RT,, Cunningham SA,, Hyman J,, Walsh J,, Arbefeville S,, Howard W,, Pruessner J,, Safwat N,, Cockerill FR,, Bossler AD,, Patel R,, Richter SS. 2012. Evaluation of the Bruker Biotyper and Vitek MS matrix-assisted laser desorption ionization–time of flight mass spectrometry systems for identification of nonfermenting gram-negative bacilli isolated from cultures from cystic fibrosis patients. J Clin Microbiol 50: 2034– 2039.

114. Desai AP,, Stanley T,, Atuan M,, McKey J,, LiPuma JJ,, Rogers B,, Jerris R. 2012. Use of matrix assisted laser desorption ionisation–time of flight mass spectrometry in a paediatric clinical laboratory for identification of bacteria commonly isolated from cystic fibrosis patients. J Clin Pathol 65: 835– 838.

115. Spilker T,, Vandamme P,, LiPuma JJ. 2013. Identification and distribution of Achromobacter species in cystic fibrosis. J Cyst Fibros 12: 298– 301.

116. Ridderberg W,, Wang M,, Nørskov-Lauritsen N. 2012. Multilocus sequence analysis of isolates of Achromobacter from patients with cystic fibrosis reveals infecting species other than Achromobacter xylosoxidans. J Clin Microbiol 50: 2688– 2694.

117. Schmidtke AJ,, Boney KO,, Martin SW,, Skoff TH,, Tondella ML,, Tatti KM. 2012. Population diversity among Bordetella pertussis isolates, United States, 1935–2009. Emerg Infect Dis 18: 1248– 1255.

118. van Amersfoorth SCM,, Schouls LS,, van der Heide HGJ,, Advani A,, Hallander HO,, Bondeson K,, von König CHW,, Riffelmann M,, Vahrenholz C,, Guiso N,, Caro V,, Njamkepo E,, He Q,, Mertsola J,, Mooi FR. 2005. Analysis of Bordetella pertussis populations in European countries with different vaccine policies. J Clin Microbiol 43: 2837– 2843.

119. Advani A,, Hallander HO,, Dalby T,, Krogfelt KA,, Guiso N,, Njamkepo E,, von König CH,, Riffelmann M,, Mooi FR,, Sandven P,, Lutynska A,, Fry NK,, Mertsola J,, He Q. 2013. Pulsed-field gel electrophoresis analysis of Bordetella pertussis isolates circulating in Europe from 1998 to 2009. J Clin Microbiol 51: 422– 428.

120. Litt DJ,, Jauneikaite E,, Tchipeva D,, Harrison TG,, Fry NK. 2012. Direct molecular typing of Bordetella pertussis from clinical specimens submitted for diagnostic quantitative (real-time) PCR. J Med Microbiol 61: 1662– 1668.

121. Van Gent M,, Bart ML,, van der Heide HG,, Heuvelman KJ,, Kallonen T,, He Q,, Mertsola J,, Advani A,, Hallander H,, Janssens K,, Hermany PW,, Mooi FR. 2011. SNP-based typing: a useful tool to study Bordetella pertussis population. PLoS One 6: e20340.

122. Kallonen T,, Mertsola J,, Mooi FR,, He Q. 2012. Rapid detection of the recently emerged Bordetella pertussis strains with the ptxP− pertussis toxin promoter allele by real-time PCR. Clin Microbiol Infect 18: E377– E379.

123. Williamson YM,, Moura H,, Simmons K,, Whitmon J,, Melnick N,, Rees J,, Woolfit A,, Schieltz DM,, Tondella ML,, Ades E,, Sampson J,, Carlone G,, Barr JR. 2012. A gel-free proteomic method for the characterization of Bordetella clinical isolates. J Microbiol Methods 90: 119– 133.

124. Mooi FR,, Bruisten S,, Linde I,, Reubsaet F,, Heuvelman K,, van der Lee S,, King AJ. 2012. Characterization of Bordetella holmesii isolates from patients with pertussis-like illness in The Netherlands. FEMS Immunol Med Microbiol 64: 289– 291.

125. Tatti KM,, Loparev VN,, Ranganathanganakammal S,, Changayil S,, Frace M,, Weil MR,, Sammons S,, Maccannell D,, Mayer LW,, Tondella ML. 2013. Draft genome sequences of Bordetella holmesii strains from blood (F627) and nasopharynx (H556). Genome Announc 1: e5613.

126. Moissenet D,, Baculard A,, Valcin M,, Marchand V,, Tournier G,, Garbarg-Chenon A,, Vu-Thien H. 1997. Colonization by Alcaligenes xylosoxidans in children with cystic fibrosis: a retrospective clinical study conducted by means of molecular epidemiological investigation. Clin Infect Dis 24: 274– 275.

127. Clermont D,, Harmant C,, Bizet CJ. 2001. Identification of strains of Alcaligenes and Agrobacterium by a polyphasic approach. J Clin Microbiol 39: 3104– 3109.

128. de Melker HE,, Versteegh FG,, Conyn-Van Spaendonck MA,, Elvers LH,, Berbers GA,, van der Zee A,, Schellekens JF. 2000. Specificity and sensitivity of high levels of immunoglobulin G antibodies to pertussis toxin in a single serum sample for diagnosis of infection with Bordetella pertussis. J Clin Microbiol 38: 800– 806.

129. Guiso N,, Berbers G,, Fry NK,, He Q,, Riffelmann M,, Wirsing von König CH,, EU Pertstrain Group. 2011. What to do and what not to do in pertussis serology: recommendations from the European reference laboratories. Eur J Clin Microbiol Infect Dis 30: 307– 312.

130. Kapasi A,, Meade BD,, Plikaytis B,, Pawlwoski L,, Martin MD,, Yoder S,, Rock MT,, Coddens S,, Hazebroeck V,, Fivet-Groyne F,, Bixler G,, Jones C,, Hildreth S,, Edwards KM,, Messonier NE,, Tondella ML. 2012. Comparative study of different sources of pertussis toxin (PT) as coating antigens in IgG anti-PT enzyme linked immunosorbent assays. Clin Vaccine Immunol 19: 64– 72.

131. Le T,, Cherry JD,, Chang SJ,, Knoll MD,, Lee ML,, Barenkamp S,, Bernstein D,, Edelman R,, Edwards KM,, Greenberg D,, Keitel W,, Treanor J,, Ward JL. 2004. Immune responses and antibody decay after immunization of adolescents and adults with an acellular pertussis vaccine: the APERT Study. J Infect Dis 190: 535– 544.

132. Baughman AL,, Bisgard KM,, Edwards KM,, Guris D,, Decker MD,, Holland K,, Meade BD,, Lynn F. 2004. Establishment of diagnostic cutoff points for levels of serum antibodies to pertussis toxin, filamentous hemagglutinin, and fimbriae in adolescents and adults in the United States. Clin Diagn Lab Immunol 11: 1045– 1053.

133. Yih WK,, Lett SM,, des Vignes FN,, Garrison KM,, Sipe PL,, Marchant CD. 2000. The increasing incidence of pertussis in Massachusetts adolescents and adults, 1989–1998. J Infect Dis 182: 1409– 1416.

134. Xing D,, Wirsing von König CH,, Newland P,, Riffelmann M,, Meade BD,, Corbel M,, Gaines-Das R. 2009. Characterization of proposed reference materials for pertussis antiserum (human) by an international collaborative study. Clin Vaccine Immunol 16: 303– 311.

135. Mertens PL,, Stals FS,, Steyerberg EW,, Richardus JH. 2007. Sensitivity and specificity of single IgA and IgG antibody concentrations for early diagnosis of pertussis in adults: an evaluation for outbreak management in public health practice. BMC Infect Dis 7: 53.

136. Pebody RG,, Gay NJ,, Giammanco A,, Baron S,, Schellekens J,, Tischer A,, Olander RM,, Andrews NJ,, Edmunds WJ,, Lecoeur H,, Lévy-Bruhl D,, Maple PA,, de Melker H,, Nardone A,, Rota MC,, Salmaso S,, Conyn-van Spaendonck MA,, Swidsinski S,, Miller E. 2005. The seroepidemiology of Bordetella pertussis infection in Western Europe. Epidemiol Infect 133: 159– 171.

137. Versteegh FG,, Mertens PI,, de Melker HE,, Roord JJ,, Schellekens JF,, Teunis PF. 2005. Age-specific long-term course of antibodies to pertussis toxin after symptomatic infection with Bordetella pertussis. Epidemiol Infect 133: 737– 748.

138. Riffelmann M,, Thiel K,, Schmetz J,, Wirsing von Koenig CH. 2010. Performance of commercial enzyme-linked immunosorbent assays for detection of antibodies to Bordetella pertussis. J Clin Microbiol 48: 4459– 4463.

139. Riffelmann M,, Hunfeld KP,, Müller I,, Xing D,, Kennerknecht N,, Wirsing von König CH. 2013. External quality assessment of pertussis serology in Germany. Eur J Clin Microbiol Infect Dis 32: 421– 423.

140. Altunaiji S,, Kukuruzovic R,, Curtis N,, Massie J. 2007. Antibiotics for whooping cough (pertussis). Cochrane Database Syst Rev 18: CD004404.

141. Zhang Q,, Li M,, Wang L,, Xin T,, He Q. 2013. High-resolution melting analysis for the detection of two erythromycin-resistant Bordetella pertussis strains carried by healthy schoolchildren in China. Clin Microbiol Infect 19: E260– E262.

142. Kadlec K,, Wiegand J,, Kehrenberg C,, Schwarz S. 2007. Studies on the mechanisms of beta-lactam resistance in Bordetella bronchiseptica. J Antimicrob Chemother 59: 396– 402.

143. Mortensen JE,, Brumbach A,, Shrycock TR. 1989. Antimicrobial susceptibility of Bordetella avium and Bordetella bronchiseptica isolates. Antimicrob Agents Chemother 33: 771– 772.

144. Schwarz S,, Aleksik E,, Grobbel M,, Lübcke-Becker A,, Werckenthin C,, Wieler LH,, Wallmann J. 2007. Antimicrobial susceptibility of Pasteurella multocida and Bordetella bronchiseptica from dogs and cats as determined in the BfT-GermVet monitoring program 2004–2006. Berl Munch Tierarztl Wochenschr 120: 423– 430.

145. Glupczynski Y,, Hansen W,, Freney J,, Yourassowsky E. 1988. In vitro susceptibility of Alcaligenes denitrificans subsp. xylosoxidans to 24 antimicrobial agents. Antimicrob Agents Chemother 32: 276– 278.

146. Saiman L,, Chen Y,, Tabibi S,, San Gabriel P,, Zhou J,, Liu Z,, Lai L,, Whittier S. 2001. Identification and antimicrobial susceptibility of Alcaligenes xylosoxidans isolated from patients with cystic fibrosis. J Clin Microbiol 39: 3942– 3945.

147. Saiman L,, Chen Y,, San Gabriel P,, Knirsch C. 2002. Synergistic activities of macrolide antibiotics against Pseudomonas aeruginosa, Burkholderia cepacia, Stenotrophomonas maltophilia, and Alcaligenes xylosoxidans isolated from patients with cystic fibrosis. Antimicrob Agents Chemother 46: 1105– 1157.

148. MacKenzie FM,, Smith SV,, Milne KE,, Griffiths K,, Legge J,, Gould IM. 2004. Antibiograms of resistant Gram-negative bacteria from Scottish CF patients. J Cyst Fibros 3: 151– 157.

149. Kay SE,, Clark RA,, White KL,, Peel MM. 2001. Recurrent Achromobacter piechaudii bacteremia in a patient with hematological malignancy. J Clin Microbiol 39: 808– 810.

150. Wang M,, Ridderberg W,, Hansen CR,, Høiby N,, Jensen-Fangel S,, Olesen HV,, Skov M,, Lemming LE,, Pressler T,, Johansen HK,, Nørskov-Lauritsen N. 2013. Early treatment with inhaled antibiotics postpones next occurrence of Achromobacter in cystic fibrosis. J Cyst Fibros 12: 638– 643.

151. Bizet C,, Tekaia F,, Philippon A. 1993. In-vitro susceptibility of Alcaligenes faecalis compared with those of other Alcaligenes spp. to antimicrobial agents including seven beta-lactams. J Antimicrob Chemother 32: 907– 910.

152. Tatti KM,, Martin SW,, Boney KO,, Brown K,, Clark TA,, Tondella ML. 2013. Qualitative assessment of pertussis diagnostics in United States laboratories. Pediatr Infect Dis J 32: 942– 945.

153. Zhang Z,, Fan X,, Gao X,, Zhang X-H. 2014. Achromobacter sediminum sp. nov., isolated from deep subseafloor sediment of South Pacific Gyre. Int J Syst Evol Microbiol 64: 2244– 2249.

154. Moon J-Y,, Lim J-M,, Ahn J-H,, Weon H-Y,, Kwon S-W,, Kim S-J. 2014. Paenalcaligenes suwonensis sp. nov., isolated from spent mushroom compost. Int J Syst Evol Microbiol 64: 882– 886.

155. Harvill ET,, Goodfield LL,, Ivanov Y,, Smallridge WE,, Meyer JA,, Cassiday PK,, Tondella ML,, Brinkac L,, Sanka R,, Kim M,, Losada L. 2014. Genome sequences of nine Bordetella holmesii strains isolated in the United States. Genome Announc 2: e00438– 14.

Tables

Bordetellaand Related Genera

/content/10.1128/9781555817381.mcm11.ch45.ch45.tab001

TABLE 1

Members of the genus Bordetella

TABLE 1

Members of the genus Bordetella

/content/10.1128/9781555817381.mcm11.ch45.ch45.tab002

TABLE 2

Possible targets for detection of Bordetella DNA by real-time PCR

TABLE 2

Possible targets for detection of Bordetella DNA by real-time PCR

/content/10.1128/9781555817381.mcm11.ch45.ch45.tab003

TABLE 3

Useful characteristics for differentiating Bordetella species a

TABLE 3

Useful characteristics for differentiating Bordetella species a

/content/10.1128/9781555817381.mcm11.ch45.ch45.tab004

TABLE 4

Possible results of Bordetella PCR and suggested interpretation

TABLE 4

Possible results of Bordetella PCR and suggested interpretation